RIL
PRAX icon

Rothschild Investment LLC’s Praxis Precision Medicines PRAX Stock Holding History

Rothschild Investment LLC’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Sell
56
-13
-19% -$4.12K ﹤0.01% 1574
2026
Q1 		$22.2K Buy
69
+19
+38% +$5.88K ﹤0.01% 1379
2025
Q4 		$14.7K Buy
50
+5
+11% +$931 ﹤0.01% 1429
2025
Q3 		$2.38K Sell
45
-5
-10% -$242 ﹤0.01% 2117
2025
Q2 		$2.1K Buy
50
+45
+900% +$1.71K ﹤0.01% 2040
2025
Q1 		$189 Sell
5
-20
-80% -$1.25K ﹤0.01% 2865
2024
Q4 		$1.92K Buy
25
+10
+67% +$724 ﹤0.01% 1825
2024
Q3 		$863 Buy
15
+10
+200% +$540 ﹤0.01% 2271
2024
Q2 		$207 Buy
+5
New +$236 ﹤0.01% 2476

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rothschild Investment LLC's PRAX Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Praxis Precision Medicines (PRAX) stake by 19% in Q2 2026, selling an estimated $4.12K and leaving 56 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Rothschild Investment LLC first reported a position in PRAX in Q2 2024 and has held it in 9 quarters since. The position peaked at $22.2K in Q1 2026. 232 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Rothschild Investment LLC held 56 shares of Praxis Precision Medicines worth $18.7K as of Q2 2026.
  • Rothschild Investment LLC sold 13 Praxis Precision Medicines shares in Q2 2026, an estimated $4.12K.
  • Praxis Precision Medicines made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1574 holding.
  • Rothschild Investment LLC first reported a position in Praxis Precision Medicines in Q2 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Praxis Precision Medicines position peaked at $22.2K in Q1 2026.
  • 232 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.